Form D · Pharmaceuticals
Aevum Longevity Corp.
Vancouver, A1 · CIK 0002076042
Offering snapshot reported Jul 9, 2025 · SEC filing
- Reported sold
- $2.25K Offering amount: $2.25K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 9, 2025 | Initial | $2,251 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-551126
Source: Form D, filed Jul 9, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Amandeep Gill | Director |
| Robert Payment | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2501 550 Burrard Street
Vancouver, A1, V6C 2B5
Phone: 604-868-1669
Vancouver, A1, V6C 2B5
Phone: 604-868-1669